Steven Erpelinck BSc. MBA
- AMS transporters
- PBPK modeling
We focus on nine societal areas.
TNO cooperates with companies, the public sector and other organisations, to apply our knowledge and expertise with and for others.
We develop knowledge not for its own sake, but for practical application.
TNO offers you the chance to do groundbreaking work and help customers and society with innovative, practical and smart solutions.
On TNO Insights you can read in-depth interviews and articles. Get inspired by TNO’s innovations!
We will also show our in vitro microbiota screening platform I-screen which can be used in preclinical phase to measure and identify microbiota induced 'human' metabolites.
A microdosing AMS study requires a very low dose (< 100ug), reduces costs, shortens the development process and ensures a reduction of lab animals during preclinical development. TNO is the only organisation in Europe with an auto-combustion based biomedical Accelerator Mass Spectrometer (AMS) that enables this research.
At the ACCP, TNO will present its capabilities in the field of microdosing AMS studies showing that these studies may accelerate and de-risk drug development. Advantages of our auto-combustion based AMS in comparison to the conventional graphitisation based AMS will be demonstrated. We look forward to meeting you at our booth, number 202.
TNO.nl collects and processes data in accordance with the applicable privacy regulations for an optimal user experience and marketing practices.
This data can easily be removed from your temporary profile page at any time.
You can also view our privacy statement or cookie-information.